Fluidigm Introduces AccuLift Laser Capture Microdissection System to Advance Translational and Clinical Pathology Research
March 10, 2020 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Expands Maxpar Antibody Portfolio for High-Multiplex Tissue Imaging
December 10, 2019 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), the global leader in high-multiplex single-scan tissue imaging, today announced the availability of...
Interpace Diagnostics Announces New York State Approval
April 23, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
State of New York Approves Commercialization of ThyraMIR® Now in Three Specimens PARSIPPANY, NJ, April 23, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today...
Interpace Diagnostics Announces Further Expansion of Thyroid Business
January 22, 2019 06:55 ET
|
Interpace Diagnostics Group, Inc.
Interpace Only Provider Validated to Offer MDx Tests on Three Distinct Platforms PARSIPPANY, NJ, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (IDXG) announced today that it...
Cofactor Genomics Launches ImmunoPrism™ Immune Profiling Kit, for Use in Clinical Sequencing Laboratories
October 30, 2018 08:00 ET
|
Cofactor Genomics
--Enables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisions-- SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Cofactor...
Cofactor Genomics Announces Clinical Validation of its Tumor Immune-Profiling Assay, ImmunoPrismTM
October 02, 2018 08:00 ET
|
Cofactor Genomics
CAP/CLIA validation of ImmunoPrismTM furthers Cofactor’s mission of leveraging RNA to build unique, transformative assays informing critical clinical decisions SAN FRANCISCO, Oct. 02, 2018 (GLOBE...
Cofactor Genomics Launches Paragon, a Comprehensive Quantitative Solid Tumor Immune Profiling Assay
February 08, 2018 08:00 ET
|
Cofactor Genomics
SAN FRANCISCO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the commercial launch of Paragon, a solid tumor...
Circulomics Awarded Phase I SBIR to Develop Nanobind Extraction Method for FFPE Samples
September 24, 2014 09:12 ET
|
Circulomics
BALTIMORE, MD--(Marketwired - September 24, 2014) - Circulomics Inc has been awarded a Phase I Small Business Innovative Research (SBIR) grant by the National Institutes of Health (NIH) to develop its...